IRWD - Ironwood Pharmaceuticals Non-GAAP EPS of $0.21 revenue of $98M May, 05 2022 07:03 AM Ironwood Pharmaceuticals Inc. Ironwood Pharmaceuticals press release (NASDAQ:IRWD): Q1 Non-GAAP EPS of $0.21. Revenue of $98M. FY22 financial guidance maintained. For further details see: Ironwood Pharmaceuticals Non-GAAP EPS of $0.21, revenue of $98M